GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Torii Pharmaceutical Co Ltd (TSE:4551) » Definitions » Shiller PE Ratio

Torii Pharmaceutical Co (TSE:4551) Shiller PE Ratio : 17.84 (As of May. 14, 2024)


View and export this data going back to 1993. Start your Free Trial

What is Torii Pharmaceutical Co Shiller PE Ratio?

As of today (2024-05-14), Torii Pharmaceutical Co's current share price is 円3930.00. Torii Pharmaceutical Co's E10 for the quarter that ended in Mar. 2024 was 円220.26. Torii Pharmaceutical Co's Shiller PE Ratio for today is 17.84.

The historical rank and industry rank for Torii Pharmaceutical Co's Shiller PE Ratio or its related term are showing as below:

TSE:4551' s Shiller PE Ratio Range Over the Past 10 Years
Min: 10.39   Med: 16.37   Max: 26.68
Current: 18.23

During the past years, Torii Pharmaceutical Co's highest Shiller PE Ratio was 26.68. The lowest was 10.39. And the median was 16.37.

TSE:4551's Shiller PE Ratio is ranked better than
68.05% of 532 companies
in the Drug Manufacturers industry
Industry Median: 25.285 vs TSE:4551: 18.23

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Torii Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2024 was 円31.270. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is 円220.26 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Torii Pharmaceutical Co Shiller PE Ratio Historical Data

The historical data trend for Torii Pharmaceutical Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Torii Pharmaceutical Co Shiller PE Ratio Chart

Torii Pharmaceutical Co Annual Data
Trend Mar14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.51 17.53 14.75 13.93 16.15

Torii Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.22 17.05 17.92 16.15 18.55

Competitive Comparison of Torii Pharmaceutical Co's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Torii Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Torii Pharmaceutical Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Torii Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Torii Pharmaceutical Co's Shiller PE Ratio falls into.



Torii Pharmaceutical Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Torii Pharmaceutical Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=3930.00/220.26
=17.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Torii Pharmaceutical Co's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Torii Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=31.27/107.2000*107.2000
=31.270

Current CPI (Mar. 2024) = 107.2000.

Torii Pharmaceutical Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 15.400 98.000 16.846
201409 28.450 98.500 30.963
201412 41.650 97.900 45.607
201503 18.830 97.900 20.619
201506 38.869 98.400 42.345
201509 24.670 98.500 26.849
201512 42.262 98.100 46.182
201603 28.390 97.900 31.087
201606 24.028 98.100 26.257
201609 9.610 98.000 10.512
201612 38.370 98.400 41.801
201703 13.850 98.100 15.135
201706 48.930 98.500 53.252
201709 36.008 98.800 39.069
201712 69.390 99.400 74.835
201803 20.290 99.200 21.926
201806 34.920 99.200 37.736
201809 24.920 99.900 26.741
201812 -38.647 99.700 -41.554
201903 1,016.430 99.700 1,092.892
201906 -83.090 99.800 -89.251
201909 9.590 100.100 10.270
201912 32.050 100.500 34.187
202003 30.730 100.300 32.844
202006 33.400 99.900 35.841
202009 25.200 99.900 27.041
202012 35.130 99.300 37.925
202103 15.530 99.900 16.665
202106 28.769 99.500 30.995
202109 35.380 100.100 37.889
202112 40.437 100.100 43.305
202203 31.400 101.100 33.295
202206 34.279 101.800 36.097
202209 35.970 103.100 37.400
202212 38.720 104.100 39.873
202303 -10.280 104.400 -10.556
202306 48.899 105.200 49.829
202309 45.590 106.200 46.019
202312 62.302 106.800 62.535
202403 31.270 107.200 31.270

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Torii Pharmaceutical Co  (TSE:4551) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Torii Pharmaceutical Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Torii Pharmaceutical Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Torii Pharmaceutical Co (TSE:4551) Business Description

Traded in Other Exchanges
N/A
Address
Torii Nihonbashi Buildingg, 4-1, Nihonbashi-Honcho, 3-chome, Chuo-ku, Tokyo, JPN, 103-8439
Torii Pharmaceutical Co Ltd is a major drug manufacturing company. The company utilizes strategic partnerships with other pharmaceutical companies in order to combine research and marketing functions. Torii's key therapeutic areas include renal diseases, hemodialysis, HIV, skin diseases, and allergens. The vast majority of the company's net mainstay product sales are derived from the renal diseases and hemodialysis operations, followed by HIV. Torii's places its strategic focus on prompt market penetration and expansion of new products as well as maximizing values of mainstay products in each priority area.

Torii Pharmaceutical Co (TSE:4551) Headlines

No Headlines